Safety evaluation of a beverage containing mulberry leaf extract

Biosci Biotechnol Biochem. 2022 Mar 21;86(4):519-527. doi: 10.1093/bbb/zbac011.

Abstract

Mulberry leaf extract (MLE) has known as inhibits elevated postprandial blood glucose level in human. Then, we conducted a randomized, double-blind placebo-controlled parallel-group trial to evaluate safety when a green tea containing MLE is consumed 3 times a day, every day for 4 weeks. The participants (n = 48) were randomly allocated into 2 groups, an MLE beverage group and a control beverage group. The subjects were instructed to drink either a 500 mL green tea containing 550 mg MLE or a 500 mL green tea not containing MLE, 3 times a day, every day, for 4 weeks. No adverse reactions were observed over the 4 weeks trial, and no difference in the incidence of adverse events between the groups. These findings demonstrate that the consumption of a green tea containing 550 mg MLE 3 times a day for 4 weeks is safe for healthy adults.

Keywords: mulberry leaf extract; randomized controlled study; safety evaluation.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Double-Blind Method
  • Fruit
  • Humans
  • Morus*
  • Plant Extracts / adverse effects
  • Postprandial Period
  • Tea

Substances

  • Plant Extracts
  • Tea